Code Bio is developing transformational, non-viral, genetic medicines to treat and potentially cure serious and life-threatening diseases.

Hatfield, PA
Joined March 2022
Code Biotherapeutics retweeted
Panelists include Tom Barnes, PhD, CEO, @Orna_TX; Susan Dillon, PhD, President & CEO, @AroBioTx; David Lockhart, PhD, President & CSO, @ReCodeTx; & Brian McVeigh, Chairman, CEO, & Co-Founder, @CodeBioTx. #ChardanGMConf #CGMC2022 #GeneticMedicines
1
2
2